SilverCrest Metals
SILV
Cars.com
CARS
Lantheus
LNTH
Collegium Pharmaceutical
COLL
Hutchmed (China)
HCM
(Q3)Jul 31, 2024 | (Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | (FY)Oct 31, 2023 | (Q4)Oct 31, 2023 | (Q3)Jul 31, 2023 | (Q2)Apr 30, 2023 | (Q1)Jan 31, 2023 | (FY)Oct 31, 2022 | (Q4)Oct 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 159.30%14.09M | -20.10%10.78M | 392.73%24.37M | -101.43%-365.58K | -785.83%-10.97M | 448.19%5.43M | 888.48%13.49M | -133.78%-8.32M | 218.56%25.52M | -90.07%1.6M |
Net income from continuing operations | -2.99%3.94M | -77.42%506.52K | -46.53%849.87K | -13.49%10.19M | -47.45%2.3M | -11.54%4.06M | 71.48%2.24M | 5.61%1.59M | 1,141.20%11.78M | 168.23%4.38M |
Operating gains losses | ---- | ---- | ---- | -373.05%-30.53K | -87.74%1.14K | -97,878.57%-68.45K | ---10K | --46.77K | -89.27%11.18K | 110.18%9.33K |
Depreciation and amortization | 12.55%960.21K | 2.08%874.89K | 4.55%878.17K | 4.04%3.41M | -0.71%855.04K | 10.53%853.17K | 5.75%857.1K | 1.26%839.94K | -1.66%3.27M | 3.98%861.16K |
Other non cash items | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 108.33%32.64K | ---- |
Change In working capital | 5,744.64%8.89M | -10.62%9.05M | 291.31%21.96M | -260.34%-14.95M | -214.57%-13.75M | 103.37%152.11K | 359.78%10.12M | -151.92%-11.48M | 97.74%9.32M | -132.61%-4.37M |
-Change in receivables | 1,326.51%12.02M | -704.00%-15.9M | 312.97%9.91M | -379.62%-6.92M | -167.86%-5.74M | 122.88%842.78K | 154.17%2.63M | -281.58%-4.65M | 126.15%2.47M | 826.06%8.45M |
-Change in payables and accrued expense | 15.07%-3.27M | 165.49%25.65M | 186.29%10.1M | -194.88%-10.72M | 47.92%-4.81M | -85.87%-3.85M | 498.26%9.66M | -155.76%-11.71M | -26.53%11.3M | -159.49%-9.24M |
-Change in other current assets | -46.87%425.84K | 258.08%658.72K | -118.36%-576.2K | 466.08%2.87M | 21.66%-648.21K | 18.15%801.53K | -118.92%-416.71K | 803.86%3.14M | 77.60%-785.21K | 76.32%-827.46K |
-Change in other working capital | -112.03%-284.13K | 22.23%-1.36M | 44.04%2.52M | 94.72%-193.03K | 7.41%-2.55M | 318.89%2.36M | -279.94%-1.75M | 273.48%1.75M | -258.73%-3.66M | -204.50%-2.75M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 159.30%14.09M | -20.10%10.78M | 392.73%24.37M | -101.43%-365.58K | -785.83%-10.97M | 448.19%5.43M | 888.48%13.49M | -133.78%-8.32M | 218.56%25.52M | -90.07%1.6M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -490.62%-1.2M | -165.98%-675.22K | -25.31%-280.54K | 0.85%-1.28M | 22.16%-599.44K | -1.85%-202.85K | -48.41%-253.86K | -48.55%-223.88K | -68.94%-1.29M | -53.66%-770.09K |
Net PPE purchase and sale | -599.42%-914.72K | -168.41%-518.37K | -16.03%-147.12K | -35.06%-761.21K | -1.31%-310.51K | -46.48%-130.78K | -69.98%-193.13K | -133.90%-126.79K | -331.50%-563.62K | -329.54%-306.51K |
Net intangibles purchase and sale | -293.16%-283.32K | -121.74%-156.84K | -37.43%-133.42K | -49.22%-528.81K | -219.05%-288.93K | 34.41%-72.06K | -23.14%-70.73K | -0.60%-97.09K | -36.02%-354.37K | -59.45%-90.56K |
Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 0.00%-373.02K | ---- |
Net other investing changes | ---- | ---- | ---- | --10K | --0 | --0 | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -490.62%-1.2M | -165.98%-675.22K | -25.31%-280.54K | 0.85%-1.28M | 22.16%-599.44K | -1.85%-202.85K | -48.41%-253.86K | -48.55%-223.88K | -68.94%-1.29M | -53.66%-770.09K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 85.32%-1.34M | 101.03%102.43K | -166.27%-11.65M | 2,782.78%6.17M | 130.26%7.65M | -588.94%-9.14M | -155.01%-9.9M | 212.84%17.57M | 114.41%214.15K | -239.46%-25.27M |
Net issuance payments of debt | 93.85%-563.64K | 109.94%960.45K | -166.07%-11.57M | 20,561.84%6.76M | 131.89%8.08M | -611.92%-9.17M | -153.90%-9.66M | 213.19%17.51M | 98.05%-33.04K | -238.27%-25.34M |
Net common stock issuance | ---840.58K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Proceeds from stock option exercised by employees | 133.52%6.24K | 114.60%42.04K | -1,084.38%-115.41K | -1,045.73%-766.03K | -6,533.46%-471.25K | -146.81%-18.62K | -949.32%-287.88K | --11.72K | --81K | --7.33K |
Net other financing activities | 22.03%55.63K | -17.83%39.11K | -17.65%40.09K | 8.23%179.86K | -38.46%38K | 17.20%45.58K | 19.39%47.59K | 89.58%48.68K | -20.18%166.18K | 32.82%61.75K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 85.32%-1.34M | 101.03%102.43K | -166.27%-11.65M | 2,782.78%6.17M | 130.26%7.65M | -588.94%-9.14M | -155.01%-9.9M | 212.84%17.57M | 114.41%214.15K | -239.46%-25.27M |
Net cash flow | ||||||||||
Beginning cash position | 14.04%115.51M | 7.45%105.82M | 4.70%92.72M | 33.12%88.56M | -14.53%97.73M | -9.06%101.29M | 3.02%98.48M | 33.12%88.56M | 12.17%66.53M | 98.15%114.34M |
Current changes in cash | 395.12%11.55M | 205.83%10.21M | 37.87%12.44M | -81.48%4.53M | 83.96%-3.92M | -246.99%-3.91M | -79.29%3.34M | -70.03%9.02M | 324.31%24.44M | -399.48%-24.44M |
Effect of exchange rate changes | -192.99%-328.29K | 2.22%-517.67K | -26.99%656.7K | 84.78%-366.77K | 18.82%-1.09M | 17.85%353.03K | -60.24%-529.41K | 186.75%899.42K | -265.55%-2.41M | -303.43%-1.34M |
End cash Position | 29.67%126.73M | 14.04%115.51M | 7.45%105.82M | 4.70%92.72M | 4.70%92.72M | -14.53%97.73M | -9.06%101.29M | 3.02%98.48M | 33.12%88.56M | 33.12%88.56M |
Free cash flow | 146.45%12.89M | -23.61%10.11M | 381.78%24.09M | -106.73%-1.66M | -1,062.21%-11.57M | 560.42%5.23M | 802.81%13.23M | -134.91%-8.55M | 222.86%24.6M | -92.48%1.2M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |